论文部分内容阅读
目的比较软通道微创穿刺引流与内科保守治疗高血压脑出血的临床疗效。方法将80例高血压脑出血患者随机分为对照组与观察组,42例对照组予以内科保守治疗,38例观察组患者行软通道微创穿刺引流治疗。比较两组住院期间的病死率、再出血率和出院后半年日常生活能力。结果观察组与对照组患者住院期间病死率分别为5.56%和11.90%(P<0.05),观察组低于对照组(P<0.05);两组再出血率分别为28.95%和28.57%,差别无统计学意义(P>0.05);治疗后半年的日常生活能力评定优良率,观察组的致残率为59.52%,显著低于对照组76.31%,差别具有统计学意义(P<0.01)。结论软通道微创治疗高血压脑出血可显著减少住院期间病死率,降低致残率,改善患者预后,提高生活质量。
Objective To compare the clinical effects of soft-channel minimally invasive puncture and drainage and conservative treatment of hypertensive intracerebral hemorrhage. Methods Eighty patients with hypertensive intracerebral hemorrhage were randomly divided into control group and observation group. 42 patients in the control group were treated conservatively. 38 patients in the observation group were treated with minimally invasive puncture and drainage with soft channel. The mortality, rebleeding rate and daily living ability of the two groups after hospital discharge were compared between the two groups. Results The mortality rates of patients in observation group and control group during hospitalization were 5.56% and 11.90% respectively (P <0.05), and those in observation group were lower than those in control group (P <0.05). The rates of rebleeding were 28.95% and 28.57% There was no significant difference between the two groups (P> 0.05). After six months of treatment, the assessment of daily living ability was excellent and excellent. The morbidity rate of the observation group was 59.52%, which was significantly lower than that of the control group (76.31%). The difference was statistically significant (P <0.01). Conclusion Minimally invasive soft-channel treatment of hypertensive intracerebral hemorrhage can significantly reduce mortality during hospitalization, reduce morbidity, improve prognosis and improve quality of life.